Transcripta Bio, Synfini announce research collaboration to identify candidate against key driver of Huntington's disease progression
Transcripta Bio, an AI─powered drug discovery company focused on neurological and neuromuscular disease, and Synfini Inc, an agile AI foundry for small─molecule drug discovery, announced results from a
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →